Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07039357

Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes

A Single Centre, Open-label Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With or Without Known T2DM: a Confirmatory Performance Evaluation of the Glyconics SW Package Delivering the Dichotomised Screening Test Results in a Known Population.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Glyconics Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A single-site, open label, confirmatory study assessing two biomarkers indicative of levels of glycaemia; glycated keratin in fingernails and glycated haemoglobin (HbA1c). Screening for diabetes

Conditions

Interventions

TypeNameDescription
DEVICENear-infrared (spectroscopy) for non-invasive assessment of glycated keratin of nailboth interventions will be applied in both participant groups

Timeline

Start date
2026-01-28
Primary completion
2026-04-30
Completion
2026-05-30
First posted
2025-06-26
Last updated
2026-03-27

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07039357. Inclusion in this directory is not an endorsement.

Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes (NCT07039357) · Clinical Trials Directory